Companies: 10,795·Total market cap: $144.5T
MorphoSys AG

MorphoSys AG

MORNASDAQHealthcare
$18.96
+$0.45(+2.43%)
Market Cap$2.9B
P/E Ratio—
52W High$19.5
52W Low$4.185
Overview
Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

MorphoSys AG (MOR) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · MOR · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-3.16mor eps ttm · mor earnings per shareEarnings history
PE Ratio (TTM)—mor pe ratio ttm · mor price to earningsPE Ratio deep dive
Revenue (TTM)$203.6Mmor revenue ttm · mor annual revenueFull revenue history
Dividend YieldNo Dividenddoes mor pay dividends · mor dividend yieldDividend history
Shares Outstanding137.2Mmor shares outstanding · mor floatShares outstanding history
Next EarningsTBAmor earnings date · mor next earningsEarnings history

Explore MorphoSys AG Data

mor stock data · financials
Market Cap$2.9Bmor market cap · mor valuation
Analyst Forecast$— · Buy
DividendsNo Dividenddoes morphosys ag pay dividends · mor dividend yield
Revenue$238.3M-14.37%morphosys ag annual revenue · mor revenue
EarningsEPS $-1.38-25.45%mor earnings · mor eps
PE Ratio—mor pe ratio · mor price to earnings

Financial Snapshot

Full Financials
FY 2023Revenue$238.3M▼ 14.37% YoY
202120222023
morphosys ag revenue · mor revenue 2023
FY 2023Net Income-$189.7M▼ 25.60% YoY
202120222023
morphosys ag net income · mor profit 2023
FY 2023EPS$-1.38▼ 25.45% YoY
202120222023
mor eps · morphosys ag earnings per share 2023
TTM:Revenue: $203.6MNet Income: -$460.3MEPS: $-3.16View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy10 analystsis mor a buy · mor analyst rating
Strong Buy
0
Buy
5
Hold
5
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$18.96Current
$—Avg Target
$—High
mor price target · mor 12 month forecast

Total: 10 · Buy rate: 50.0%

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+2.43%
3M+3.10%
YTD+96.68%
1Y+155.53%
5Y-34.39%

About MorphoSys AG

CEOArkadius Pichota
IPO DateApr 19, 2018
Employees464
CountryDE
Websitemorphosys.com

MorphoSys AG is a commercial-stage biopharmaceutical company dedicated to the discovery, advancement, and marketing of innovative therapeutic antibodies aimed at treating cancer and autoimmune disorde…

BiotechnologyHealthcareNASDAQADRDE

what is morphosys ag · mor stock overview · morphosys ag company profile · who is morphosys ag ceo · mor NASDAQ · morphosys ag headquarters · morphosys ag business segments

About Stock Overview & Key Data

MorphoSys AG (MOR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 19, 2018. As of the latest trading session, MOR stock price is $18.96, with a market capitalization of $2.9B. The stock has returned +155.53% over the past 12 months and +96.68% year-to-date.

According to 10 Wall Street analysts, the consensus rating for MorphoSys AG stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, MorphoSys AG reported revenue of $238.3M and net income of -$189.7M. For detailed data — including MorphoSys AG revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, MorphoSys AG (MOR) stock price is $18.96. The stock is traded on NASDAQ under the ticker symbol MOR. The 52-week range is $4.18 – $19.50.

MOR stock priceMOR quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice